RJT
MEDP icon

Raymond James Trust’s Medpace MEDP Stock Holding History

Raymond James Trust’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$252K Buy
754
+194
+35% +$73.7K 0.01% 1131
2024
Q2 		$231K Sell
560
-12
-2% -$4.75K 0.01% 1122
2024
Q1 		$231K Sell
572
-91
-14% -$32K 0.01% 1116
2023
Q4 		$203K Buy
+663
New +$179K 0.01% 1136
2023
Q3 		– Sell
-971
Closed -$233K – 1191
2023
Q2 		$233K Buy
+971
New +$202K 0.01% 1038
2022
Q4 		– Sell
-1,464
Closed -$230K – 1149
2022
Q3 		$230K Buy
+1,464
New +$234K 0.01% 916

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Raymond James Trust's MEDP Position: Q3 2024 in Review

Raymond James Trust increased its Medpace (MEDP) stake by 35% in Q3 2024, buying an estimated $73.7K and bringing the position to 754 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #1131.

Raymond James Trust first reported a position in MEDP in Q3 2022 and has held it in 6 quarters since. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Raymond James Trust held 754 shares of Medpace worth $252K as of Q3 2024.
  • Raymond James Trust bought 194 Medpace shares in Q3 2024, an estimated $73.7K.
  • Medpace made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #1131 holding.
  • Raymond James Trust first reported a position in Medpace in Q3 2022 and has held it in 6 quarters since.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.